Replimune (REPL) Payables (2018 - 2026)
Replimune (REPL) recorded Payables of $5.96 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 6.9% from $6.4 million a year earlier but up 39.8% from the prior quarter.
Replimune (REPL) Payables (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune reported Payables of $6.67 million, down 46.5% from FY2025.
- Annual Payables has a five-year compound annual growth rate of 23.2% (FY2021 to FY2026).
- Across earlier fiscal years, Payables came in at $12.46 million in FY2025 (+383.4%), $2.58 million in FY2024 (-51.9%), $5.36 million in FY2023 (+43.7%) and $3.73 million in FY2022 (+58.5%).
- Quarterly Payables has ranged from $864,000 in fiscal Q1 2025 to $15.48 million in fiscal Q1 2026 over the past five years.
- On a year-over-year basis, Payables has declined for five consecutive quarters, with growth averaging 42.3% over the last seven quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 383.4% in fiscal Q4 2025, against a decline of 82.3% in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $4.26 million (Q1 2027), $6.67 million (Q4 2026) and $5.65 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - | 5.96 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.96 Mn |
| Jun 30, 2026 | 4.26 Mn |
| Mar 31, 2026 | 6.67 Mn |
| Dec 31, 2025 | 5.65 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | 15.48 Mn |
| Mar 31, 2025 | 12.46 Mn |
| Dec 31, 2024 | 7.19 Mn |
| Sep 30, 2024 | 8.41 Mn |
| Jun 30, 2024 | 864,000.00 |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 4.37 Mn |
| Jun 30, 2023 | 4.88 Mn |
| Mar 31, 2023 | 5.36 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 4.48 Mn |
| Mar 31, 2022 | 3.73 Mn |
| Dec 31, 2021 | 3.92 Mn |
Replimune Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=REPL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();